Safety of Drugs during Pregnancy and Breastfeeding in Cystic Fibrosis Patients
Safety of Drugs during Pregnancy and Breastfeeding in Cystic Fibrosis Patients
About this item
Full title
Author / Creator
Publisher
Basel, Switzerland: S. Karger AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel, Switzerland: S. Karger AG
Subjects
More information
Scope and Contents
Contents
Health management of cystic fibrosis (CF) patients should be maximized during pregnancy and breastfeeding because of its significant impact on the maternal and newborn outcomes. Thus, numerous drugs will have to be continued during pregnancy and lactation. Most of the drugs representing CF treatment lines cross the placenta or are excreted into hum...
Alternative Titles
Full title
Safety of Drugs during Pregnancy and Breastfeeding in Cystic Fibrosis Patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_healthsolutions_A637175669
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_healthsolutions_A637175669
Other Identifiers
ISSN
0025-7931
E-ISSN
1423-0356
DOI
10.1159/000444088
